Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SACTION 2501: Neoadjuvant SBRT + Sintilimab + Chemotherapy for Locally Advanced NSCLC
NCT07309952Phase 2Recruiting
- Start
- Dec 2025
- Primary completion
- Oct 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab in non-small cell lung cancer (NSCLC). Started Dec 2025; status: recruiting.
02
Drugs
sintilimab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT07309952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07309952.